- Protocol Short Name and Number: RICHI, 1204
- Protocol Long Name: Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies.
- Protocol (PDF)
- Protocol Synopsis (PDF)
- Informed Consent and Assent
- Frequently Asked Questions
- Key Personnel
- BMT CTN # 1204 Protocol Co-Chair: Carl Allen, MD
- BMT CTN # 1204 Protocol Co-Chair: M. Pulsipher, MD
- BMT CTN # 1204 Protocol Officer: Mary Eapen, MD
- BMT CTN # 1204 Medical Monitor: Liza Thiel, MD
- Keywords: RICHI, Hemophagocytic, Primary Immune Deficiencies, Epstein-Barr Virus, EBV, Epstein Barr, CAEBV, Chronic Granulomatous Disease, CGD, X-linked Hyper IgM Syndrome, HIGM1, IPEX, Leukocyte Adhesion Syndrome, LAD-I, LAD, Hemophagocytic Lymphohistiocytosis, HLH, Reduced Intensity Conditioning, Allogeneic Transplant, Allo Transplant, Allo, Unrelated, Unrelated Donor, Pediatric, Child, Children, Teen, Adolescent
Accrual for the BMT CTN 1204 trial closed on December 4, 2015.